Type of Material in Repair of Congenital Diaphragmatic Hernia

Status Terminated

Clinical Trial Summary

The objective of this study is to evaluate the use of 2 different types of biosynthetic material for the repair of congenital diaphragmatic hernia. The research question is: what is the best material for repairing large congenital diaphragmatic hernias? The primary outcome variable is recurrence.

Clinical Trial Description

At birth, the estimated gestational age and birth weight will be recorded, as well as the presence and type of other congenital anomalies.

Prior to operation, the length of time from birth to repair will be recorded. To determine the severity of physiologic compromise, the need and type of ventilator support as well as the need and length of ECMO support will be recorded. The amount of time between ECMO discontinuation and repair will be recorded. The respiratory support required at the time of operation will be recorded.

At operation, the size of the defect will be measured and recorded. The location (right versus left) will be recorded and special notation will be recorded regarding any areas where no diaphragmatic rim is present. The operative time and charges will be recorded.

After the operation, the length of ventilator support, time to feeds, hospital stay, and hospital charges will be recorded. Post-operative complications such as bleeding complications, pneumonia, sepsis, gastroesophageal reflux, early recurrence and bowel obstruction will be recorded. Future operations and type of procedure will be recorded. If future operations in the abdomen are required, the amount and severity of intraperitoneal adhesions will be noted and recorded. Mortality will be recorded.

After discharge, commensurate with standard current clinical practice, all patients will receive a follow-up appointment with a chest x-ray at 6 months and 1 year of life. After this time, follow-up appointments will be made each year for the first 5 years of life and imaging will be obtained on the basis of symptoms. Any further follow-up will be as needed for symptoms. Oxygen requirements, findings at follow-up and future hospitalization will be recorded, particularly looking at the presence or absence of hernia recurrence. The study will mature and effectively close when all subjects have reached 5 year follow-up. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00257946
Study type	Interventional
Source	Children's Mercy Hospital Kansas City
Contact
Status	Terminated
Phase	Phase 3
Start date	December 2005
Completion date	August 2007

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05100693` - Smart Removal for Congenital Diaphragmatic Hernia	N/A
Recruiting	`NCT05450653` - Trial of FETO for Severe Congenital Diaphragmatic Hernia	N/A
Terminated	`NCT04140669` - Automated Myocardial Performance Index Using Samsung HERA W10
Recruiting	`NCT05201144` - A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)	Phase 2
Not yet recruiting	`NCT06281717` - Fetal Endotracheal Occlusion (FETO) in Fetuses With Severe Congenital Diaphragmatic Hernia	N/A
Recruiting	`NCT04429750` - Intact Cord Resuscitation in CDH	N/A
Recruiting	`NCT03750266` - 3D Animation and Models to Aid Management of Fetal CDH
Not yet recruiting	`NCT05421676` - Fetal Endoscopic Tracheal Occlusion for CDH (CDH)	N/A
Completed	`NCT01243229` - Genetic Analysis of Congenital Diaphragmatic Disorders
Recruiting	`NCT04583644` - Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)	N/A
Completed	`NCT03314233` - Delayed Cord Clamping for Congenital Diaphragmatic Hernia	N/A
Recruiting	`NCT04114578` - Exploratory Observational Prospective Study in Neonatal and Pediatric Congenital Diaphragmatic Hernia
Completed	`NCT03666767` - Management and Outcomes of Congenital Anomalies in Low-, Middle- and High-Income Countries
Recruiting	`NCT02986087` - Feto-Endoscopic Tracheal Occlusion (FETO) for Left Congenital Diaphragmatic Hernia	N/A
Recruiting	`NCT03674372` - Fetoscopic Endoluminal Tracheal Occlusion	N/A
Active, not recruiting	`NCT05839340` - Neurally Adjusted Ventilatory Assist for Neonates With Congenital Diaphragmatic Hernias	N/A
Enrolling by invitation	`NCT05962346` - Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia	N/A
Withdrawn	`NCT04186039` - Functional Evaluation of the Fetal Lung by Functional Magnetic Resonance Imaging - Blood Oxygenation Level Dependent (MRI-BOLD), in Congenital Diaphragmatic and Parietal Malformations	N/A
Unknown status	`NCT01302977` - Fetal Tracheal Occlusion in Severe Diaphragmatic Hernia: a Randomized Trial	Phase 2
Recruiting	`NCT03179371` - Proteomic Profiling for Congenital Diaphragmatic Hernia

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.